HAPEXITY Trademark

Trademark Overview

On Monday, July 22, 2019, a trademark application was filed for HAPEXITY with the United States Patent and Trademark Office. The USPTO has given the HAPEXITY trademark a serial number of 79267555. The federal status of this trademark filing is REGISTERED as of Tuesday, March 17, 2020. This trademark is owned by Merck KGaA. The HAPEXITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use in the field of oncology, namely pharmaceutical preparations for treatment of cancer
hapexity

General Information

Serial Number79267555
Word MarkHAPEXITY
Filing DateMonday, July 22, 2019
Status700 - REGISTERED
Status DateTuesday, March 17, 2020
Registration Number6010515
Registration DateTuesday, March 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use in the field of oncology, namely pharmaceutical preparations for treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, August 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 29, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 28, 2020FINAL DISPOSITION PROCESSED
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 17, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, January 4, 2020NOTIFICATION PROCESSED BY IB
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 22, 2019REFUSAL PROCESSED BY IB
Thursday, November 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 2, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 2, 2019REFUSAL PROCESSED BY MPU
Wednesday, October 16, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 15, 2019NON-FINAL ACTION WRITTEN
Wednesday, October 9, 2019ASSIGNED TO EXAMINER
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 26, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 19, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

hapexity pharmaceutical preparations treatment cancer namely field human oncology